Resources from the same session
4350 - Time to second progression (PFS2) and second subsequent therapy (TSST) for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) treated with maintenance (mt) olaparib (ola) – Phase III SOLO1 trial
Presenter: Ana Oaknin
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
2325 - Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) in the Phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)
Presenter: Michael Friedlander
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
2019 - Validation of the Geriatric Vulnerability Score (GVS) in older ovarian cancer (oOC) patients: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study
Presenter: Fabian Tinquaut
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
4563 - Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)
Presenter: Yvette Drew
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
4592 - Analysis of tumor samples from SOLO1: frequency of BRCA specific loss of heterozygosity (LOH) and progression-free survival (PFS) according to homologous recombination repair deficiency (HRD)-LOH score
Presenter: Charlie Gourley
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
4751 - Immune-related gene expression signatures (irGES) in patients (pts) with ovarian clear cell carcinomas (OCCC) – a multicenter analysis
Presenter: Valerie Heong
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
Poster Discussion – Gynaecological cancers - Invited Discussant 995PD, 996PD, 997PD and 1190PD
Presenter: Sven Mahner
Session: Poster Discussion – Gynaecological cancers
Resources:
Slides
Webcast
1518 - Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on adjuvant therapy
Presenter: Carien Creutzberg
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract